SMALL CELL LUNG CANCER RECURRENT

Clinical trials for SMALL CELL LUNG CANCER RECURRENT explained in plain language.

Never miss a new study

Get alerted when new SMALL CELL LUNG CANCER RECURRENT trials appear

Sign up with your email to follow new studies for SMALL CELL LUNG CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough lung cancer: experimental drug enters human testing

Disease control Ongoing

This early-stage study is testing a new oral drug called Debio 0123 in combination with two standard chemotherapy drugs (carboplatin and etoposide). It aims to find a safe dose and see if the combination can help control tumors in adults whose small cell lung cancer has returned …

Matched conditions: SMALL CELL LUNG CANCER RECURRENT

Phase: PHASE1 • Sponsor: Debiopharm International SA • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

SMALL CELL LUNG CANCER RECURRENT

Get alerted when new SMALL CELL LUNG CANCER RECURRENT trials appear

New hope for tough lung cancer: experimental drug enters human testing